Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (14198)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Dec 22, 2015 (publication date) through Apr 18, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Psychiatry
ISSN
2220-3206
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Sarkar S, Hillner K, Velligan DI. Conceptualization and treatment of negative symptoms in schizophrenia. World J Psychiatr 2015; 5(4): 352-361 [PMID: 26740926 DOI: 10.5498/wjp.v5.i4.352] |
|---|---|
| URL: | https://www.wjgnet.com/2220-3206/full/v5/i4/352.htm |
| Number | Citing Articles |
| 1 |
Laura A. Faith, Tania Lecomte, Marc Corbière, Audrey Francoeur, Catherine Hache-Labelle, Paul H. Lysaker. Metacognition Is Uniquely Related to Concurrent and Prospective Assessments of Negative Symptoms Independent of Verbal Memory in Serious Mental Illness. Journal of Nervous & Mental Disease 2020; 208(11): 837 doi: 10.1097/NMD.0000000000001219
|
| 2 |
Danielle Schlosser, Timothy Campellone, Daniel Kim, Brandy Truong, Silvia Vergani, Charlie Ward, Sophia Vinogradov. Feasibility of PRIME: A Cognitive Neuroscience-Informed Mobile App Intervention to Enhance Motivated Behavior and Improve Quality of Life in Recent Onset Schizophrenia. JMIR Research Protocols 2016; 5(2): e77 doi: 10.2196/resprot.5450
|
| 3 |
Shafkat Jahan, Darren Wraith, Michael P. Dunne, Suchithra Naish. Assessing evidence for seasonality of hospital admissions for schizophrenia in Queensland, Australia: a time series observational study. International Journal of Biometeorology 2021; 65(12): 2025 doi: 10.1007/s00484-021-02160-7
|
| 4 |
Samantha E. Yohn, P. Jeffrey Conn. Pick Your Model Wisely: Understanding the Negative Symptoms of Schizophrenia in Rodent Models. ACS Chemical Neuroscience 2019; 10(1): 33 doi: 10.1021/acschemneuro.8b00553
|
| 5 |
Samuel David Clark, Anissa Abi-Dargham. The Role of Dynorphin and the Kappa Opioid Receptor in the Symptomatology of Schizophrenia: A Review of the Evidence. Biological Psychiatry 2019; 86(7): 502 doi: 10.1016/j.biopsych.2019.05.012
|
| 6 |
Carl Delfin, Greg E. Reckless, Ingeborg Bolstad, Inge Groote, Ole A. Andreassen, Jimmy Jensen. Exploring the Effects of an Acute Dose of Antipsychotic Medication on Motivation-mediated BOLD Activity Using fMRI and a Perceptual Decision-making Task. Neuroscience 2020; 440: 146 doi: 10.1016/j.neuroscience.2020.05.035
|
| 7 |
Alexandre González-Rodríguez, Mary V. Seeman, Armand Guàrdia, Mentxu Natividad, Eloïsa Román, Eduard Izquierdo, José A. Monreal. A Review of Cardiovascular Risk Factors in Women with Psychosis. Women 2023; 3(2): 200 doi: 10.3390/women3020016
|
| 8 |
Clementine Jane Edwards, Philippa Garety, Amy Hardy. The relationship between depressive symptoms and negative symptoms in people with non-affective psychosis: a meta-analysis. Psychological Medicine 2019; 49(15): 2486 doi: 10.1017/S0033291719002381
|
| 9 |
Ana Carolina Issy, João Francisco C. Pedrazzi, Anna Beatriz Saito van Oosten, Thiago Checheto, Rafaela R. Silva, François Noël, Elaine Del-Bel. Effects of Doxycycline in Swiss Mice Predictive Models of Schizophrenia. Neurotoxicity Research 2020; 38(4): 1049 doi: 10.1007/s12640-020-00268-z
|
| 10 |
Julia A.C. Case, Holly Sullivan-Toole, Matthew Mattoni, Ross Jacobucci, Erika E. Forbes, Thomas M. Olino. Evaluating the item-level factor structure of anhedonia. Journal of Affective Disorders 2022; 299: 215 doi: 10.1016/j.jad.2021.11.069
|
| 11 |
Ana Izquierdo, María Cabello, Alejandro de la Torre-Luque, Rosa Ayesa-Arriola, Esther Setien-Suero, Jacqueline Mayoral-van-Son, Javier Vazquez-Bourgon, Jose Luis Ayuso-Mateos, Benedicto Crespo-Facorro. A network analysis approach to functioning problems in first psychotic episodes and their relationship with duration of untreated illness: Findings from the PAFIP cohort. Journal of Psychiatric Research 2021; 136: 483 doi: 10.1016/j.jpsychires.2020.10.019
|
| 12 |
Matthias Pillny, Björn Schlier, Tania M. Lincoln. “I just don't look forward to anything”. How anticipatory pleasure and negative beliefs contribute to goal-directed activity in patients with negative symptoms of psychosis. Schizophrenia Research 2020; 222: 429 doi: 10.1016/j.schres.2020.03.059
|
| 13 |
Giuseppe Carrà, Cristina Crocamo, Matthias Angermeyer, Traolach Brugha, Mondher Toumi, Paul Bebbington. Positive and negative symptoms in schizophrenia: A longitudinal analysis using latent variable structural equation modelling. Schizophrenia Research 2019; 204: 58 doi: 10.1016/j.schres.2018.08.018
|
| 14 |
Delphine Raucher-Chéné, Michael Bodnar, Katie M Lavigne, Ashok Malla, Ridha Joober, Martin Lepage. Dynamic Interplay Between Insight and Persistent Negative Symptoms in First Episode of Psychosis: A Longitudinal Study. Schizophrenia Bulletin 2022; 48(1): 211 doi: 10.1093/schbul/sbab079
|
| 15 |
Sohei Kimoto, Manabu Makinodan, Toshifumi Kishimoto. Neurobiology and treatment of social cognition in schizophrenia: Bridging the bed-bench gap. Neurobiology of Disease 2019; 131: 104315 doi: 10.1016/j.nbd.2018.10.022
|
| 16 |
Benedicto Crespo-Facorro, Miguel Bernardo, Josep Maria Argimon, Manuel Arrojo, Maria Fe Bravo-Ortiz, Ana Cabrera-Cifuentes, Julián Carretero-Román, Manuel A. Franco-Martín, Paz García-Portilla, Josep Maria Haro, José Manuel Olivares, Rafael Penadés, Javier del Pino-Montes, Julio Sanjuán, Celso Arango. Eficacia, eficiencia y efectividad en el tratamiento multidimensional de la esquizofrenia: proyecto Rethinking. Revista de Psiquiatría y Salud Mental 2017; 10(1): 4 doi: 10.1016/j.rpsm.2016.09.001
|
| 17 |
Andrea de Bartolomeis, Mirko Manchia, Federica Marmo, Licia Vellucci, Felice Iasevoli, Annarita Barone. Glycine Signaling in the Framework of Dopamine-Glutamate Interaction and Postsynaptic Density. Implications for Treatment-Resistant Schizophrenia. Frontiers in Psychiatry 2020; 11 doi: 10.3389/fpsyt.2020.00369
|
| 18 |
L. Kalisova, J. Michalec, F. Dechterenko, P. Silhan, M. Hyza, M. Chlebovcova, M. Brenova, O. Bezdicek. Impact of cognitive performance and negative symptoms on psychosocial functioning in Czech schizophrenia patients. Schizophrenia 2023; 9(1) doi: 10.1038/s41537-023-00374-9
|
| 19 |
Armida Mucci, Annarita Vignapiano, István Bitter, Stephen F. Austin, Camille Delouche, Sonia Dollfus, Andreas Erfurth, W. Wolfgang Fleischhacker, Giulia M. Giordano, Igor Gladyshev, Birte Glenthøj, Karoline Gütter, Alex Hofer, Jan Hubeňák, Stefan Kaiser, Jan Libiger, Ingrid Melle, Mette Ø. Nielsen, Oleg Papsuev, Janusz K. Rybakowski, Gabriele Sachs, Alp Üçok, Pawel Wojciak, Silvana Galderisi. A large European, multicenter, multinational validation study of the Brief Negative Symptom Scale. European Neuropsychopharmacology 2019; 29(8): 947 doi: 10.1016/j.euroneuro.2019.05.006
|
| 20 |
A. J. Culbreth, E. K. Moran, D. M. Barch. Effort-cost decision-making in psychosis and depression: could a similar behavioral deficit arise from disparate psychological and neural mechanisms?. Psychological Medicine 2018; 48(6): 889 doi: 10.1017/S0033291717002525
|
| 21 |
Lilian Yanqing Li, Nicole R. Karcher, John G. Kerns, Christie K. Fung, Elizabeth A. Martin. The subjective-objective deficit paradox in schizotypy extends to emotion regulation and awareness. Journal of Psychiatric Research 2019; 111: 160 doi: 10.1016/j.jpsychires.2019.01.026
|
| 22 |
Wondale Getinet Alemu, Clemence Due, Eimear Muir-Cochrane, Lillian Mwanri, Telake Azale, Anna Ziersch. Quality of life among people living with mental illness and predictors in Africa: a systematic review and meta-analysis. Quality of Life Research 2023; doi: 10.1007/s11136-023-03525-8
|
| 23 |
Hiroki Okada, Dsisuke Hirano, Takamichi Taniguchi, Hugo Schnack. Impact of Negative Symptom Domains and Other Clinical Characteristics on Functional Outcomes in Patients with Schizophrenia. Schizophrenia Research and Treatment 2021; 2021: 1 doi: 10.1155/2021/8864352
|
| 24 |
Tanvir RANA, Valentina ANDRÉ. From evidence to clinical experience: three cases of community patients with negative symptoms of schizophrenia and treated with cariprazine. Minerva Psychiatry 2023; 64(2) doi: 10.23736/S2724-6612.22.02362-4
|
| 25 |
Pradilka Perera, Ganeya Gajaram, Danish Qureshi, Manpreet Gill, Amod Thanju, Afrina Zaman, Patrice Fouron, Ayodeji Jolayemi. Use of Bupropion in the Management of Negative Symptom Schizophrenia: A Case Series. Cureus 2022; doi: 10.7759/cureus.23518
|
| 26 |
Lauren Luther, Melanie W. Fischer, Ruth L. Firmin, Michelle P. Salyers. Clarifying the overlap between motivation and negative symptom measures in schizophrenia research: A meta-analysis. Schizophrenia Research 2019; 206: 27 doi: 10.1016/j.schres.2018.10.010
|
| 27 |
Takahiko Nagamine, Nobuyuki Yamaoka, Masaru Nakamura. Iron Depletion Affects Dopamine Neurotransmissions. Clinical Neuropsychopharmacology and Therapeutics 2016; 7(0): 9 doi: 10.5234/cnpt.7.9
|
| 28 |
Lulu Yao, Zongliang Wang, Di Deng, Rongzhen Yan, Jun Ju, Qiang Zhou. The impact of D-cycloserine and sarcosine on in vivo frontal neural activity in a schizophrenia-like model. BMC Psychiatry 2019; 19(1) doi: 10.1186/s12888-019-2306-1
|
| 29 |
Maria Francisca Intan Primasiwi Lolobua, Khairina Khairina, Ida Aju Kusuma Wardani, Angelina M. Mirna Santoso. Negative Symptoms Management in Schizophrenia. Jurnal Psikiatri Surabaya 2021; 10(1): 6 doi: 10.20473/jps.v10i1.20607
|
| 30 |
Jan P A M Bogers, George Hambarian, Maykel Michiels, Jentien Vermeulen, Lieuwe de Haan. Risk Factors for Psychotic Relapse After Dose Reduction or Discontinuation of Antipsychotics in Patients With Chronic Schizophrenia: A Systematic Review and Meta-analysis. Schizophrenia Bulletin Open 2020; 1(1) doi: 10.1093/schizbullopen/sgaa002
|
| 31 |
Rona Hanani Simamora, Bahagia Loebis, Muhammad Surya Husada, Elmeida Effendy. Folic Acid and Vitamin B12 Supplementation on Male Patients with Schizophrenia Predominant Negative Symptoms. Current Nutrition & Food Science 2020; 16(1): 98 doi: 10.2174/1573401314666180620142607
|
| 32 |
Judith M Gault, Rachel Davis, Nicola G Cascella, Elyn R Saks, Iluminada Corripio-Collado, William S Anderson, Ann Olincy, John A Thompson, Edith Pomarol-Clotet, Akira Sawa, Zafiris J Daskalakis, Nir Lipsman, Aviva Abosch. Approaches to neuromodulation for schizophrenia. Journal of Neurology, Neurosurgery & Psychiatry 2018; 89(7): 777 doi: 10.1136/jnnp-2017-316946
|
| 33 |
Pedro Caldana Gordon, Leandro da Costa Lane Valiengo, Vanessa Jesus Rodrigues de Paula, Ricardo Galhardoni, Ulf Ziemann, Daniel Ciampi de Andrade, Andre Russowsky Brunoni. Changes in motor cortical excitability in schizophrenia following transcranial direct current stimulation. Progress in Neuro-Psychopharmacology and Biological Psychiatry 2019; 90: 43 doi: 10.1016/j.pnpbp.2018.11.004
|
| 34 |
Rubina Attar, Martin Berg Johansen, Jan Brink Valentin, Jørgen Aagaard, Svend Eggert Jensen, Peter John McKenna. Treatment following myocardial infarction in patients with schizophrenia. PLOS ONE 2017; 12(12): e0189289 doi: 10.1371/journal.pone.0189289
|
| 35 |
Jan P.A.M. Bogers, Peter F.J. Schulte, Theo G. Broekman, Peter Moleman, Lieuwe de Haan. Dose reduction of high-dose first-generation antipsychotics or switch to ziprasidone in long-stay patients with schizophrenia: A 1-year double-blind randomized clinical trial. European Neuropsychopharmacology 2018; 28(9): 1024 doi: 10.1016/j.euroneuro.2018.06.005
|
| 36 |
Johnny Downs, Harry Dean, Suzannah Lechler, Nicola Sears, Rashmi Patel, Hitesh Shetty, Matthew Hotopf, Tamsin Ford, Marinos Kyriakopoulos, Covadonga M Diaz-Caneja, Celso Arango, James H MacCabe, Richard D Hayes, Laura Pina-Camacho. Negative Symptoms in Early-Onset Psychosis and Their Association With Antipsychotic Treatment Failure. Schizophrenia Bulletin 2019; 45(1): 69 doi: 10.1093/schbul/sbx197
|
| 37 |
Benedicto Crespo-Facorro, Miguel Bernardo, Josep Maria Argimon, Manuel Arrojo, Maria Fe Bravo-Ortiz, Ana Cabrera-Cifuentes, Julián Carretero-Román, Manuel A. Franco-Martín, Paz García-Portilla, Josep Maria Haro, José Manuel Olivares, Rafael Penadés, Javier del Pino-Montes, Julio Sanjuán, Celso Arango. Effectiveness, efficiency and efficacy in the multidimensional treatment of schizophrenia: Rethinking project. Revista de Psiquiatría y Salud Mental (English Edition) 2017; 10(1): 4 doi: 10.1016/j.rpsmen.2016.09.002
|
| 38 |
Rosa Ayesa-Arriola, Jose María Pelayo Terán, Esther Setién-Suero, Karl Neergaard, Susana Ochoa, Mariluz Ramírez-Bonilla, Rocío Pérez-Iglesias, Benedicto Crespo-Facorro. Patterns of recovery course in early intervention for FIRST episode non-affective psychosis patients: The role of timing. Schizophrenia Research 2019; 209: 245 doi: 10.1016/j.schres.2019.01.032
|
| 39 |
Leandro Valiengo, Pedro Caldana Gordon, Juliana Barbosa de Carvalho, Rosa Maria Rios, Stephanie Koebe, Mauricio Henrique Serpa, Martinus van de Bilt, Acioly Lacerda, Helio Elkis, Wagner Farid Gattaz, André Russowsky Brunoni. Schizophrenia TreAtment with electRic Transcranial Stimulation (STARTS): design, rationale and objectives of a randomized, double-blinded, sham-controlled trial. Trends in Psychiatry and Psychotherapy 2019; 41(2): 104 doi: 10.1590/2237-6089-2018-0047
|
| 40 |
Giuseppe Carrà, Cristina Crocamo, Francesco Bartoli, Matthias Angermeyer, Traolach Brugha, Mondher Toumi, Paul Bebbington. The mediating role of depression in pathways linking positive and negative symptoms in schizophrenia. A longitudinal analysis using latent variable structural equation modelling. Psychological Medicine 2020; 50(4): 566 doi: 10.1017/S0033291719000321
|
| 41 |
María García-López, Miguel Alonso-Sánchez, Itziar Leal, David Martín-Hernández, Javier R. Caso, Covadonga M. Díaz-Caneja, Álvaro Andreu-Bernabeu, Celso Arango, Roberto Rodriguez-Jimenez, Luis Sánchez-Pastor, Marina Díaz-Marsá, Blanca Mellor-Marsá, Ángela Ibáñez, Norberto Malpica, Maria-Fe Bravo-Ortiz, Enrique Baca-Garcia, Jose Luis Ayuso-Mateos, Ana Izquierdo, Juan C. Leza, Miriam Ayora, Sara Boi, Aggie Nuñez-Doyle, Olga Jiménez-Rodríguez, Julia García Albea, Jose Rodríguez Quijano, Jerónimo Saiz-Ruiz, Leticia León-Quismondo, Ainoa Muñoz-Sanjose, Paz Vidal-Villegas, Lucia Albarracin García, Maria Luisa Barrigon-Esteve, Iosune Torio. The relationship between negative symptoms, social cognition, and social functioning in patients with first episode psychosis. Journal of Psychiatric Research 2022; 155: 171 doi: 10.1016/j.jpsychires.2022.08.004
|
| 42 |
Michał Wroński, Jerzy Samochowiec, Justyna Pełka-Wysiecka, Paweł Liśkiewicz, Przemysław Bieńkowski, Błażej Misiak. Deficit Symptomatology of Schizophrenia Is Associated with Attenuated Taste Identification: Findings from a Cross-Sectional Study. Brain Sciences 2022; 12(11): 1520 doi: 10.3390/brainsci12111520
|
| 43 |
Kelsey Huling, Paul H. Lysaker, Laura Faith, Helena García-Mieres. Addressing negative symptoms in schizophrenia through Metacognitive Reflection and Insight Therapy: An illustrated Case Study. QUADERNI DI PSICOTERAPIA COGNITIVA 2021; (48): 36 doi: 10.3280/qpc48-2021oa12139
|
| 44 |
Qian Zhang, Yajie Wan, Xinzhe Du, Yao Gao, Xiao Wang, Kewen Wu, Xiaohu Zheng, Yu Wang, Cheng Zhao, Li Li, Xianju Guo, Xinrong Li, Sha Liu, Yong Xu. Association between neuropeptide Y gene polymorphism and antipsychotics effect. Frontiers in Psychiatry 2022; 13 doi: 10.3389/fpsyt.2022.1014952
|
| 45 |
Gisela Mezquida, Bibiana Cabrera, Miquel Bioque, Silvia Amoretti, Antonio Lobo, Ana González-Pinto, Ana Espliego, Iluminada Corripio, Eduard Vieta, Josefina Castro-Fornieles, Daniel Bergé, Maria J. Escartí, Ángela Ibañez, Rafael Penadés, Ana M. Sánchez-Torres, Miguel Bernardo, Ana Meseguer, Emilio Fernandez-Egea, Jorge Vidal, Mara Parellada, Anna Alonso, Mireia Rabella, Patricia Vega, Amaia Ugarte, Helena Andrés-Bergareche, Fabiola Modrego, Julio Sanjuan, Eduardo J. Aguilar, Antoni Bulbena, Anna Mané, Marina Garriga, Ivette Morilla, Immaculada Baeza, Elena de la Serna, Fernando Contreras, Auria Albacete, Julio Bobes, M. Paz García-Portilla, Miguel Gutiérrez, Rafael Segarra, Isabel Morales-Muñoz, Roberto Rodriguez-Jimenez, Anna Butjosa, Judith Usall, Salvador Sarró, Ramón Landin-Romero, Jerónimo Saiz, Vicent Balanzá-Martínez. The course of negative symptoms in first-episode schizophrenia and its predictors: A prospective two-year follow-up study. Schizophrenia Research 2017; 189: 84 doi: 10.1016/j.schres.2017.01.047
|
| 46 |
Eman Masoud Abd El Gayed, Mohamed Soliman Rizk, Ahmed Nabil Ramadan, Noha Rabie Bayomy. mRNA Expression of the CUB and Sushi Multiple Domains 1 (CSMD1) and Its Serum Protein Level as Predictors for Psychosis in the Familial High-Risk Children and Young Adults. ACS Omega 2021; 6(37): 24128 doi: 10.1021/acsomega.1c03637
|
| 47 |
Katja Savolainen, Jouni Ihalainen, Aaro J. Jalkanen, Markus M. Forsberg. Selective adrenergic alpha2C receptor antagonist ameliorates acute phencyclidine-induced schizophrenia-like social interaction deficits in rats. Psychopharmacology 2019; 236(4): 1245 doi: 10.1007/s00213-018-5130-2
|
| 48 |
Homa Seyedmirzaei, Saba Katebian, Donya Pourkand, Giulia Cattarinussi, Fabio Sambataro, Paolo Brambilla, Giuseppe Delvecchio. Effects of COVID-19 pandemic on depression in patients with schizophrenia: A mini-review of the current evidence. Journal of Affective Disorders 2023; 332: 143 doi: 10.1016/j.jad.2023.03.087
|
| 49 |
Tongeji E. Tungaraza. Significant weight loss following clozapine use, how is it possible? A case report and review of published cases and literature relevant to the subject. Therapeutic Advances in Psychopharmacology 2016; 6(5): 335 doi: 10.1177/2045125316649534
|
| 50 |
Jelle Sjoerd Vogel, Jojanneke Bruins, Steven de Jong, Henderikus Knegtering, Agna A. Bartels-Velthuis, Richard Bruggeman, Frederike Jörg, Marieke G.H.M. Pijnenborg, Wim Veling, Ellen Visser, Mark van der Gaag, Stynke Castelein. Satisfaction with social connectedness as a predictor for positive and negative symptoms of psychosis: A PHAMOUS study. Schizophrenia Research 2021; 238: 121 doi: 10.1016/j.schres.2021.10.004
|
| 51 |
Matthias Pillny, Tania M. Lincoln. The demotivating effect of social exclusion: An experimental test of a psychosocial model on the development of negative symptoms in psychosis. Schizophrenia Research 2020; 215: 330 doi: 10.1016/j.schres.2019.10.005
|
| 52 |
Jui-Fen Cheng, Chung - Ying Chen, Mei-Chu Lin, Xuan-Yi Huang. To explore the efficacy of community rehabilitation for facilitating daily function among patients with mental illness. Perspectives in Psychiatric Care 2018; 54(4): 580 doi: 10.1111/ppc.12283
|
| 53 |
Adam J Culbreth, Erin K Moran, Wasita Mahaphanit, Molly A Erickson, Megan A Boudewyn, Michael J Frank, Deanna M Barch, Angus W MacDonald, J Daniel Ragland, Steven J Luck, Steven M Silverstein, Cameron S Carter, James M Gold. A Transdiagnostic Study of Effort-Cost Decision-Making in Psychotic and Mood Disorders. Schizophrenia Bulletin 2024; 50(2): 339 doi: 10.1093/schbul/sbad155
|
| 54 |
Linda Swanson, Matthias Schwannauer, Tim Bird, Emma Eliasson, Audrey Millar, Steffen Moritz, Helen Griffiths. Metacognitive training modified for negative symptoms: A feasibility study. Clinical Psychology & Psychotherapy 2022; 29(3): 1068 doi: 10.1002/cpp.2692
|